HGF and Splenomegaly: However, patients with LGF and HGF experienced similar symptomatology, comparable rates and severity of splenomegaly, and similar QoL scores at baseline, which may be explained by the fact that this study only included patients for whom treatment with ruxolitinib was deemed appropriate.